Health
The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant – DocWire News
Transplantation. 2021 Nov 9. doi: 10.1097/TP.0000000000003983. Online ahead of print.ABSTRACTBACKGROUND: In kidney patients COVID-19…
Transplantation. 2021 Nov 9. doi: 10.1097/TP.0000000000003983. Online ahead of print.
ABSTRACT
BACKGROUND: In kidney patients COVID-19 is associated with severely increased morbidity and mortality. A comprehensive comparison of the immunogenicity, tolerability,…
Continue Reading
-
Business16 hours ago$10,000 invested in ANZ shares 5 years ago is now worth…
-
General19 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
General16 hours agoStephanie Scott’s murder caused a ‘seismic’ shock in Leeton, and the hurt remains
-
Noosa News19 hours agoRates on hold; pressure builds for cuts in May